PROCEPT BioRobotics ( (PRCT) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Procept Biorobotics Corp. experienced a notable stock price movement despite reporting strong Q1 revenue of $69.2M, which exceeded expectations due to increased adoption of its Hydros system. However, Truist lowered the company’s price target from $90 to $70, citing concerns about potential impacts from global tariff rates on future gross margins. The company remains optimistic, maintaining its full-year 2025 guidance, signaling confidence in its growth strategies.
More about PROCEPT BioRobotics
YTD Price Performance: -33.02%
Average Trading Volume: 983,947
Technical Sentiment Signal: Buy
Current Market Cap: $2.89B
For further insights into PRCT stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.